Document Detail


Systemic treatment of severe acne with a retinoic acid derivative, isotretinoin.
MedLine Citation:
PMID:  6231496     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-eight patients with severe acne and one with hidradenitis suppurativa and acne were treated for 12 to 16 weeks with a new synthetic retinoid, isotretinoin (Roaccutane). The average dose was 0.56 mg/kg/day. Patients were seen weekly for four weeks and then fortnightly for the remaining treatment period, being evaluated both qualitatively and quantitatively. Twenty-five patients had an excellent response. Two to five months after the end of treatment no patient had relapsed. No patient withdrew because of side effects, but all suffered dry lips. This study confirms the potential of isotretinoin in the treatment of severe acne.
Authors:
J M Wishart
Related Documents :
20708076 - A new mucoadhesive dosage form for the management of oral lichen planus: formulation st...
15996416 - Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% ...
10354026 - Long-term, intermittent treatment of chronic hand eczema with mometasone furoate.
7272706 - Cryotherapy versus electrocautery in the treatment of genital warts.
9805696 - A comparison of techniques for placement of double-lumen endobronchial tubes.
9050706 - Laparoscopic bipolar coagulation for the conservative treatment of adenomyomata.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The New Zealand medical journal     Volume:  97     ISSN:  0028-8446     ISO Abbreviation:  N. Z. Med. J.     Publication Date:  1984 Feb 
Date Detail:
Created Date:  1984-05-04     Completed Date:  1984-05-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401067     Medline TA:  N Z Med J     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  115-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / drug therapy*
Acute Disease
Adult
Capsules
Cheilitis / chemically induced
Drug Evaluation
Female
Follow-Up Studies
Humans
Isotretinoin
Male
Time Factors
Tretinoin / administration & dosage,  adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Capsules; 302-79-4/Tretinoin; 4759-48-2/Isotretinoin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence for presynaptic inhibition of muscle spindle Ia afferents in man.
Next Document:  Effect of a single injection of cyclophosphamide on immunization therapy of metastases remaining aft...